$ORKA
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.
Healthcare
Sector
Biotechnology
Industry
Lawrence Otto Klein
CEO
28
Employees
$41.31
Current Price
$34.82M
Market Cap
Insider Activity Statistics
Aggregated buying and selling activity by time period
| Period | Type | Insiders | Transactions | Value | Shares | Buy/Sell Ratio |
|---|---|---|---|---|---|---|
| 1 week | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 8 | $455,333.66 | 11,098 | ||
| 2 weeks | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 8 | $455,333.66 | 11,098 | ||
| 1 month | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 10 | $623,155.25 | 16,098 | ||
| 2 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 12 | $849,713.92 | 23,098 | ||
| 3 months | Buys | 0 | 0 | - | - | All Sells |
| Sells | 5 | 17 | $1,443,213.45 | 43,098 | ||
See activity going back 12 months โ create a free account | ||||||
Insider Transactions
Recent purchases and sales by company insiders
Upcoming Earnings
Scheduled earnings reports
No upcoming earnings scheduled
Past Earnings
Historical earnings results
EPS
Estimated-$0.64
Actual-$648.55
Miss
Revenue
EstimatedN/A
ActualN/A
EPS
Estimated-$0.61
ActualN/A
Revenue
EstimatedN/A
ActualN/A
3 more earnings records available โ create a free account to see 12 months of history